Exit Strategies for Healthcare Employment Agreements
Best Practices for Preparing Your Company for Exit
What's Important to Get Right in the Term Sheet?
Staying on Track and Giving Back with Bill Spruill
Inside the UK Legal Startup Scene, with Henry Humphreys
Preparing A Company For Sale - A Podcast with Janathan Allen
Terminating Your Physician Employment Contract: Knowing your Exit Strategy
The Exit: Everything You Need to Know but Didn’t Know to Ask about Startup Acquisitions
Selling Your Government Contract Business: Plan Today for a Stronger Tomorrow, Part 1 of 2
The Grass is Greener: The State of the Cannabis Industry - Where Do We Go from Here?
Exit Worth Celebrating – It’s Never Too Early to Plan for Your Exit
Strategic Growth Paths of Top Small Business Government Contractors
Roadmap to Joint Venture Agreements: Legal and Accounting Considerations
Exit Strategies for GOVCONs with Set Aside Contracts: 2021 Insights and Lessons Learned from Business Owners and Advisors
Ledgers and Law: Start With an Ending in Mind When Building a New Business
Exiting From the Valley of the Shadow of Death: Successful Growth Strategies for Small Businesses...
Williams Mullen's COVID-19 Comeback Plan: Landlord and Tenant Negotiations for Existing Commercial Leases Amid the COVID-19 Pandemic
Investment Management Update – Exit Strategies
Is Your Health Care Facility Prepared for an Active Shooter?
Stephanie Pindyck Costantino Talks Domestic Oil and Gas M&A with The Deal
As we move through 2025, the phrase “finding alpha” has become the mantra for private equity (PE) investors focused on the consumer sector. Confidence in the sector remains robust, but the narrative has shifted: it is no...more
In a typical bull market, private equity sponsors exit out of portfolio assets through IPOs, strategic sales and sponsor-to-sponsor buyouts. But the 2025 deal market has proven to be neither typical nor robust....more
Patience is proving to be a virtue for a private equity industry that began 2024 sitting on more than 28,000 portfolio companies valued at more than $3 trillion, according to a report by Bain & Company, as average hold...more
Wilson Sonsini’s inaugural Biotech Summit will address topics of critical importance to Biotech and Biopharmaceutical companies, including early and late-stage venture financing, partnering strategies, current and future AI...more
After a touch-and-go few years, the environment for exits like IPOs and mergers is beginning to show signs of life. And with new green shoots forming, there’s no better time for up-and-coming companies to ensure they're...more
Entrepreneurs? Launching a start-up? The first question you should ask yourself is what is your exit strategy. If you do not know the answer, you should stop and make a plan, because your exit strategy is your company’s...more
Amid intense focus on investor liquidity (and paths to potential liquidity) in private companies, we provide an update on developments around direct listings as an alternative to traditional IPOs in the United States. On...more
New this year, we will be presenting legal education in Las Vegas in conjunction with MJBizCon. We are incredibly excited to finish off our educational year speaking about liquidity events for your clients - how to make an...more
Access to capital is critical for life sciences companies. Securing funding can be a lengthy and complex process compounded by the need to plan for various exit transaction scenarios. Register now for this one-hour,...more